HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): John E. Mayer, Jr. Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Burns, S. A. Articles by Briscoe, D. M. Search for Related Content PubMed PubMed Citation Articles by Burns, S. A. Articles by Briscoe, D. M.

J Thorac Cardiovasc Surg 1995;110:924-933
© 1995 Mosby, Inc.

SURGERY FOR CONGENITAL HEART DISEASE

P-SELECTIN EXPRESSION IN MYOCARDIUM OF CHILDREN UNDERGOING CARDIOPULMONARY BYPASS

Boston, Mass.

Supported by the Charles Hood Foundation and a Charles Janeway Award of the Children's Hospital, Boston, Mass. (D. M. B.).

Received for publication Dec. 20, 1994. Accepted for publication March 3, 1995. Address for reprints: David M. Briscoe, MD, Division of Nephrology, Children's Hospital, 300 Longwood Ave., Boston, MA 02115.

Abstract

Cardiopulmonary bypass is a planned support technique that results in a period of myocardial ischemia and reperfusion. In addition, it is associated with an inflammatory response likely involving endothelial cell activation. In previous studies, we showed that E-selectin and intercellular adhesion molecule-1 (ICAM-1) messenger ribonucleic acid (mRNA) are increased in human myocardium after cardiopulmonary bypass. We have now examined the expression of P-selectin mRNA by ribonuclease protection in paired atrial biopsy specimens from 12 patients before and after cardiopulmonary bypass. By means of immunocytochemistry, we have also examined the endothelial cell surface expression of P-selectin protein, as well as that of E-selectin and ICAM-1 in three additional patients. Patient ages ranged from 1 day to 8.5 years (median 12 months), and cardiopulmonary bypass times ranged from 46 to 196 minutes (median 144 minutes). By ribonuclease protection, there was marked variability in the expression of P-selectin in biopsy specimens before bypass. However, when compared with prebypass levels, P-selectin mRNA decreased modestly in 10 of 12 patients after bypass (median decrease 1.5-fold, p = 0.016). As seen with immunocytochemistry, P-selectin protein was distributed diffusely through the vascular bed on large vessels and small vessels before bypass but was virtually absent on capillaries in specimens taken after bypass. E-selectin, which was absent in prebypass biopsy specimens, was induced in one of the three specimens after bypass, but no change in ICAM-1 protein expression above baseline was noted. We also find that cultured human endothelial cells treated with tumor necrosis factor-in doses which induce ICAM-1 mRNA simultaneously decrease their expression of P-selectin mRNA as compared with untreated cells. These observations suggest that endothelial P-selectin is transcriptionally downregulated after cardiopulmonary bypass at times when E-selectin and ICAM-1 are induced. Furthermore, we find that E-selectin and ICAM-1 are expressed at times and at sites where P-selectin is absent. Although it is possible that P-selectin may have been induced and lost at early times before reperfusion, these data suggest that endothelial P-selectin plays a limited role in the inflammatory response that ensues after cardiopulmonary bypass. (J THORACCARDIOVASCSURG1995; 110:924-33)

This article has been cited by other articles:

				D. P. Nelson, S. Burns Wechsler, T. Miura, A. Stagg, J. W. Newburger, J. E. Mayer Jr, and E. J. Neufeld Myocardial immediate early gene activation after cardiopulmonary bypass with cardiac ischemia-reperfusion Ann. Thorac. Surg., January 1, 2002; 73(1): 156 - 162. [Abstract] [Full Text] [PDF]

				M. P Vallely, P. G Bannon, C. F Hughes, and L. Kritharides Endothelial Cell Adhesion Molecules and Cardiopulmonary Bypass Asian Cardiovasc Thorac Ann, December 1, 2001; 9(4): 349 - 355. [Abstract] [Full Text] [PDF]

				L. Yao, H. Setiadi, L. Xia, Z. Laszik, F. B. Taylor, and R. P. McEver Divergent Inducible Expression of P-Selectin and E-Selectin in Mice and Primates Blood, December 1, 1999; 94(11): 3820 - 3828. [Abstract] [Full Text] [PDF]

				J. Pan, L. Xia, and R. P. McEver Comparison of Promoters for the Murine and Human P-selectin Genes Suggests Species-specific and Conserved Mechanisms for Transcriptional Regulation in Endothelial Cells J. Biol. Chem., April 17, 1998; 273(16): 10058 - 10067. [Abstract] [Full Text] [PDF]

				J. Pan, L. Xia, L. Yao, and R. P. McEver Tumor Necrosis Factor-alpha - or Lipopolysaccharide-induced Expression of the Murine P-selectin Gene in Endothelial Cells Involves Novel kappa B Sites and a Variant Activating Transcription Factor/cAMP Response Element J. Biol. Chem., April 17, 1998; 273(16): 10068 - 10077. [Abstract] [Full Text] [PDF]

				L. Xia, J. Pan, L. Yao, and R. P. McEver A Proteasome Inhibitor, an Antioxidant, or a Salicylate, but not a Glucocorticoid, Blocks Constitutive and Cytokine-Inducible Expression of P-Selectin in Human Endothelial Cells Blood, March 1, 1998; 91(5): 1625 - 1632. [Abstract] [Full Text] [PDF]

				E. M. Boyle Jr, T. H. Pohlman, M. C. Johnson, and E. D. Verrier Endothelial Cell Injury in Cardiovascular Surgery: The Systemic Inflammatory Response Ann. Thorac. Surg., January 1, 1997; 63(1): 277 - 284. [Abstract] [Full Text]

				E. M. Boyle Jr, T. H. Pohlman, C. J. Cornejo, and E. D. Verrier Endothelial Cell Injury in Cardiovascular Surgery: Ischemia-Reperfusion Ann. Thorac. Surg., December 1, 1996; 62(6): 1868 - 1875. [Abstract] [Full Text]

				E. D. Verrier and E. M. Boyle Jr Endothelial Cell Injury in Cardiovascular Surgery Ann. Thorac. Surg., September 1, 1996; 62(3): 915 - 922. [Abstract] [Full Text]